164 related articles for article (PubMed ID: 16971075)
1. Supercritical antisolvent precipitation of PHBV microparticles.
Costa MS; Duarte AR; Cardoso MM; Duarte CM
Int J Pharm; 2007 Jan; 328(1):72-7. PubMed ID: 16971075
[TBL] [Abstract][Full Text] [Related]
2. Preparation of ethyl cellulose/methyl cellulose blends by supercritical antisolvent precipitation.
Duarte AR; Gordillo MD; Cardoso MM; Simplício AL; Duarte CM
Int J Pharm; 2006 Mar; 311(1-2):50-4. PubMed ID: 16423476
[TBL] [Abstract][Full Text] [Related]
3. Study of poly(L-lactide) microparticles based on supercritical CO2.
Chen AZ; Pu XM; Kang YQ; Liao L; Yao YD; Yin GF
J Mater Sci Mater Med; 2007 Dec; 18(12):2339-45. PubMed ID: 17569002
[TBL] [Abstract][Full Text] [Related]
4. Preparation of biodegradable microparticles using solution-enhanced dispersion by supercritical fluids (SEDS).
Ghaderi R; Artursson P; Carlfors J
Pharm Res; 1999 May; 16(5):676-81. PubMed ID: 10350010
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent.
Young TJ; Johnston KP; Mishima K; Tanaka H
J Pharm Sci; 1999 Jun; 88(6):640-50. PubMed ID: 10350502
[TBL] [Abstract][Full Text] [Related]
6. Rifampicin microparticles production by supercritical antisolvent precipitation.
Reverchon E; De Marco I; Della Porta G
Int J Pharm; 2002 Aug; 243(1-2):83-91. PubMed ID: 12176297
[TBL] [Abstract][Full Text] [Related]
7. Micronization of insulin from halogenated alcohol solution using supercritical carbon dioxide as an antisolvent.
Snavely WK; Subramaniam B; Rajewski RA; Defelippis MR
J Pharm Sci; 2002 Sep; 91(9):2026-39. PubMed ID: 12210049
[TBL] [Abstract][Full Text] [Related]
8. Ampicillin Nanoparticles Production via Supercritical CO2 Gas Antisolvent Process.
Esfandiari N; Ghoreishi SM
AAPS PharmSciTech; 2015 Dec; 16(6):1263-9. PubMed ID: 25771736
[TBL] [Abstract][Full Text] [Related]
9. Preparation and physicochemical properties of 10-hydroxycamptothecin (HCPT) nanoparticles by supercritical antisolvent (SAS) process.
Zhao X; Zu Y; Jiang R; Wang Y; Li Y; Li Q; Zhao D; Zu B; Zhang B; Sun Z; Zhang X
Int J Mol Sci; 2011; 12(4):2678-91. PubMed ID: 21731466
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.
Sui X; Wei W; Yang L; Zu Y; Zhao C; Zhang L; Yang F; Zhang Z
Int J Pharm; 2012 Feb; 423(2):471-9. PubMed ID: 22183131
[TBL] [Abstract][Full Text] [Related]
11. Characterization and biological evaluation of paclitaxel-loaded poly(L-lactic acid) microparticles prepared by supercritical CO2.
Kang Y; Wu J; Yin G; Huang Z; Liao X; Yao Y; Ouyang P; Wang H; Yang Q
Langmuir; 2008 Jul; 24(14):7432-41. PubMed ID: 18547089
[TBL] [Abstract][Full Text] [Related]
12. Formation of inhalable rifampicin-poly(L-lactide) microparticles by supercritical anti-solvent process.
Patomchaiviwat V; Paeratakul O; Kulvanich P
AAPS PharmSciTech; 2008; 9(4):1119-29. PubMed ID: 18989787
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of drug delivery characteristics of microspheres of PMMA-PCL-cholesterol obtained by supercritical-CO2 impregnation and by dissolution-evaporation techniques.
Elvira C; Fanovich A; Fernández M; Fraile J; San Román J; Domingo C
J Control Release; 2004 Sep; 99(2):231-40. PubMed ID: 15380633
[TBL] [Abstract][Full Text] [Related]
14. Supercritical fluid assisted atomization introduced by an enhanced mixer for micronization of lysozyme: Particle morphology, size and protein stability.
Du Z; Guan YX; Yao SJ; Zhu ZQ
Int J Pharm; 2011 Dec; 421(2):258-68. PubMed ID: 22001535
[TBL] [Abstract][Full Text] [Related]
15. Preparation of budesonide and budesonide-PLA microparticles using supercritical fluid precipitation technology.
Martin TM; Bandi N; Shulz R; Roberts CB; Kompella UB
AAPS PharmSciTech; 2002; 3(3):E18. PubMed ID: 12916933
[TBL] [Abstract][Full Text] [Related]
16. Formation of bioerodible polymeric microspheres and microparticles by rapid expansion of supercritical solutions.
Tom JW; Debenedetti PG
Biotechnol Prog; 1991; 7(5):403-11. PubMed ID: 1369363
[TBL] [Abstract][Full Text] [Related]
17. Supercritical antisolvent production of biodegradable micro- and nanoparticles for controlled delivery of paclitaxel.
Lee LY; Wang CH; Smith KA
J Control Release; 2008 Jan; 125(2):96-106. PubMed ID: 18054107
[TBL] [Abstract][Full Text] [Related]
18. Preparation and physicochemical properties of vinblastine microparticles by supercritical antisolvent process.
Zhang X; Zhao X; Zu Y; Chen X; Lu Q; Ma Y; Yang L
Int J Mol Sci; 2012 Oct; 13(10):12598-607. PubMed ID: 23202916
[TBL] [Abstract][Full Text] [Related]
19. Supercritical antisolvent co-precipitation of rifampicin and ethyl cellulose.
Djerafi R; Swanepoel A; Crampon C; Kalombo L; Labuschagne P; Badens E; Masmoudi Y
Eur J Pharm Sci; 2017 May; 102():161-171. PubMed ID: 28302396
[TBL] [Abstract][Full Text] [Related]
20. Effect of supercritical fluid density on nanoencapsulated drug particle size using the supercritical antisolvent method.
Kalani M; Yunus R
Int J Nanomedicine; 2012; 7():2165-72. PubMed ID: 22619552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
